• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 27 of 38
Vaccine breakthroughs are unleashing a ‘value rally.’ Here’s what investors should know
Newsletters
Vaccine breakthroughs are unleashing a ‘value rally.’ Here’s what investors should know
By Bernhard WarnerNovember 17, 2020
Moderna says its COVID-19 vaccine is 94.5% effective
Health
Moderna says its COVID-19 vaccine is 94.5% effective
By Robert Langreth and BloombergNovember 16, 2020
Moderna shares soar as markets bet its COVID vaccine trial is on the same track as Pfizer’s
Health
Moderna shares soar as markets bet its COVID vaccine trial is on the same track as Pfizer’s
By Robert Langreth and BloombergNovember 12, 2020
The vaccine jolt fades, sinking global stocks—except for this one surprising sector
Newsletters
The vaccine jolt fades, sinking global stocks—except for this one surprising sector
By Bernhard WarnerNovember 12, 2020
Cold storage requirements will create a vast logistical nightmare for distributing COVID-19 vaccine
Health
Cold storage requirements will create a vast logistical nightmare for distributing COVID-19 vaccine
By BloombergNovember 11, 2020
Eli Lilly is granted emergency approval for COVID-19 antibody drug by the FDA
Health
Eli Lilly is granted emergency approval for COVID-19 antibody drug by the FDA
By Riley Griffin and BloombergNovember 10, 2020
Creating a COVID vaccine is only half the battle
Health
Creating a COVID vaccine is only half the battle
By Sy MukherjeeNovember 9, 2020
J.P. Morgan analysts call these 25 stocks ‘short’ candidates as a COVID vaccine gets closer
Finance
J.P. Morgan analysts call these 25 stocks ‘short’ candidates as a COVID vaccine gets closer
By Lee CliffordNovember 9, 2020
Election-2020-Market-Reaction
Finance
Stocks rise on game-changing news: A new President and a possible vaccine
By Anne SradersNovember 9, 2020
Medical syringes are seen with Pfizer company logo displayed on a screen in the background in this illustration photo taken in Poland on October 12, 2020.
Finance
Pfizer’s blockbuster vaccine report flips the markets on their head—pandemic stocks sink, nearly everything else soars
By David MeyerNovember 9, 2020
Pfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections
Health
Pfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections
By Robert Langreth, Naomi Kresge, Riley Griffin and BloombergNovember 9, 2020
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
Health
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
By Suzi Ring, James Paton and BloombergNovember 5, 2020
COVID vaccine science
Health
The science behind the leading COVID vaccine candidates
By Sy MukherjeeNovember 3, 2020
Two tales of innovation from CVS and Pfizer
Newsletters
Two tales of innovation from CVS and Pfizer
By Sy MukherjeeOctober 29, 2020
Pfizer’s high-tech plan to track every dose of its experimental COVID vaccine
Conferences
Pfizer’s high-tech plan to track every dose of its experimental COVID vaccine
By Sy MukherjeeOctober 27, 2020
1...
  • 25
  • 26
  • 27
  • 28
  • 29
...38
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Success
Elon Musk on MacKenzie Scott giving away $26 billion of her fortune: 'Sadly,' it makes the world a worse placeplaceholder alt text
By Sydney LakeJune 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.